Targeting the target of rapamycin (TOR): looking to mother nature Eric K. Rowinsky Editorial 27 April 2011 Pages: 1 - 4
Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma Sumanta Kumar PalRobert A. Figlin Review 12 April 2011 Pages: 5 - 16
Mechanisms of mTOR inhibitor resistance in cancer therapy Jennifer S. CarewKevin R. KellySteffan T. Nawrocki Review 09 March 2011 Pages: 17 - 27
The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas Sushma VemulapalliAlain MitaMonica Mita Review 28 April 2011 Pages: 29 - 39
Aging and cancer: can mTOR inhibitors kill two birds with one drug? Zelton Dave SharpArlan Richardson Review 11 March 2011 Pages: 41 - 51
Mammalian target of rapamycin as a target in hematological malignancies Kevin R. KellyJulie H. RoweJennifer S. Carew Review 17 April 2011 Pages: 53 - 61